Ruby Nanomed
Business Description Early metastases detection is the single most important factor to save lives. Our innovative automated detection process allows doctors to detect metastases earlier while being faster cost-effective way. RUBYnanome's workflow delivers a full prognostic report for therapy monitoring and patient stratification in 2 hours. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
Tags Health Care, Muscle-invasive, Circulating
Website https://rubynanomed.com/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
Ruby Nanomed? We're happy to assist you with our
Startup Sourcing service.